| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of presynaptic active zone | 1.68e-05 | 8 | 16 | 2 | GO:0098882 | |
| GeneOntologyMolecularFunction | protein domain specific binding | 4.66e-04 | 875 | 16 | 5 | GO:0019904 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 5.09e-04 | 42 | 16 | 2 | GO:0098918 | |
| GeneOntologyBiologicalProcess | regulation of calcium-dependent activation of synaptic vesicle fusion | 1.34e-05 | 7 | 17 | 2 | GO:0150037 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic vesicle fusion to presynaptic active zone membrane | 4.96e-05 | 13 | 17 | 2 | GO:0031632 | |
| GeneOntologyBiologicalProcess | calcium-dependent activation of synaptic vesicle fusion | 4.96e-05 | 13 | 17 | 2 | GO:0099502 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic vesicle membrane organization | 4.96e-05 | 13 | 17 | 2 | GO:1901634 | |
| GeneOntologyBiologicalProcess | negative regulation of fibrinolysis | 5.78e-05 | 14 | 17 | 2 | GO:0051918 | |
| GeneOntologyBiologicalProcess | regulation of fibrinolysis | 1.08e-04 | 19 | 17 | 2 | GO:0051917 | |
| GeneOntologyBiologicalProcess | regulation of synaptic vesicle fusion to presynaptic active zone membrane | 1.20e-04 | 20 | 17 | 2 | GO:0031630 | |
| GeneOntologyBiologicalProcess | positive regulation of vesicle fusion | 1.20e-04 | 20 | 17 | 2 | GO:0031340 | |
| GeneOntologyBiologicalProcess | regulation of synaptic vesicle membrane organization | 1.20e-04 | 20 | 17 | 2 | GO:1901632 | |
| GeneOntologyBiologicalProcess | regulation of cell-cell adhesion mediated by cadherin | 1.33e-04 | 21 | 17 | 2 | GO:2000047 | |
| GeneOntologyBiologicalProcess | fibrinolysis | 2.56e-04 | 29 | 17 | 2 | GO:0042730 | |
| GeneOntologyBiologicalProcess | positive regulation of hemostasis | 2.93e-04 | 31 | 17 | 2 | GO:1900048 | |
| GeneOntologyBiologicalProcess | synaptic vesicle fusion to presynaptic active zone membrane | 2.93e-04 | 31 | 17 | 2 | GO:0031629 | |
| GeneOntologyBiologicalProcess | synaptic vesicle priming | 2.93e-04 | 31 | 17 | 2 | GO:0016082 | |
| GeneOntologyBiologicalProcess | positive regulation of blood coagulation | 2.93e-04 | 31 | 17 | 2 | GO:0030194 | |
| GeneOntologyBiologicalProcess | vesicle fusion to plasma membrane | 3.13e-04 | 32 | 17 | 2 | GO:0099500 | |
| GeneOntologyBiologicalProcess | regulation of angiogenesis | 3.27e-04 | 420 | 17 | 4 | GO:0045765 | |
| GeneOntologyBiologicalProcess | positive regulation of coagulation | 3.53e-04 | 34 | 17 | 2 | GO:0050820 | |
| GeneOntologyBiologicalProcess | regulation of vasculature development | 3.57e-04 | 430 | 17 | 4 | GO:1901342 | |
| GeneOntologyBiologicalProcess | negative regulation of angiogenesis | 3.74e-04 | 175 | 17 | 3 | GO:0016525 | |
| GeneOntologyBiologicalProcess | regulation of vesicle fusion | 3.74e-04 | 35 | 17 | 2 | GO:0031338 | |
| GeneOntologyBiologicalProcess | negative regulation of blood vessel morphogenesis | 3.93e-04 | 178 | 17 | 3 | GO:2000181 | |
| GeneOntologyBiologicalProcess | synaptic vesicle membrane organization | 3.96e-04 | 36 | 17 | 2 | GO:0048499 | |
| GeneOntologyBiologicalProcess | negative regulation of vasculature development | 4.06e-04 | 180 | 17 | 3 | GO:1901343 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion mediated by cadherin | 7.65e-04 | 50 | 17 | 2 | GO:0044331 | |
| GeneOntologyBiologicalProcess | visual perception | 8.29e-04 | 230 | 17 | 3 | GO:0007601 | |
| GeneOntologyBiologicalProcess | sensory perception of light stimulus | 8.61e-04 | 233 | 17 | 3 | GO:0050953 | |
| GeneOntologyBiologicalProcess | cell junction organization | 8.94e-04 | 974 | 17 | 5 | GO:0034330 | |
| GeneOntologyBiologicalProcess | cell junction maintenance | 1.29e-03 | 65 | 17 | 2 | GO:0034331 | |
| GeneOntologyBiologicalProcess | sensory perception | 1.38e-03 | 1072 | 17 | 5 | GO:0007600 | |
| GeneOntologyBiologicalProcess | negative regulation of blood coagulation | 1.45e-03 | 69 | 17 | 2 | GO:0030195 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | 1.48e-03 | 1090 | 17 | 5 | GO:0022603 | |
| GeneOntologyBiologicalProcess | negative regulation of hemostasis | 1.49e-03 | 70 | 17 | 2 | GO:1900047 | |
| GeneOntologyBiologicalProcess | negative regulation of coagulation | 1.58e-03 | 72 | 17 | 2 | GO:0050819 | |
| GeneOntologyBiologicalProcess | positive regulation of wound healing | 1.62e-03 | 73 | 17 | 2 | GO:0090303 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | 1.71e-03 | 1125 | 17 | 5 | GO:0035239 | |
| GeneOntologyBiologicalProcess | lamellipodium assembly | 1.90e-03 | 79 | 17 | 2 | GO:0030032 | |
| GeneOntologyBiologicalProcess | regulation of cell junction assembly | 1.94e-03 | 309 | 17 | 3 | GO:1901888 | |
| GeneOntologyBiologicalProcess | angiogenesis | 2.29e-03 | 708 | 17 | 4 | GO:0001525 | |
| GeneOntologyBiologicalProcess | regulation of blood coagulation | 2.51e-03 | 91 | 17 | 2 | GO:0030193 | |
| GeneOntologyBiologicalProcess | growth | 2.58e-03 | 1235 | 17 | 5 | GO:0040007 | |
| GeneOntologyBiologicalProcess | regulation of hemostasis | 2.62e-03 | 93 | 17 | 2 | GO:1900046 | |
| GeneOntologyBiologicalProcess | positive regulation of response to wounding | 2.62e-03 | 93 | 17 | 2 | GO:1903036 | |
| GeneOntologyBiologicalProcess | metanephros development | 2.73e-03 | 95 | 17 | 2 | GO:0001656 | |
| GeneOntologyBiologicalProcess | regulation of coagulation | 2.79e-03 | 96 | 17 | 2 | GO:0050818 | |
| GeneOntologyBiologicalProcess | negative regulation of wound healing | 2.90e-03 | 98 | 17 | 2 | GO:0061045 | |
| GeneOntologyBiologicalProcess | lamellipodium organization | 2.96e-03 | 99 | 17 | 2 | GO:0097581 | |
| GeneOntologyBiologicalProcess | neuron projection development | 3.07e-03 | 1285 | 17 | 5 | GO:0031175 | |
| GeneOntologyBiologicalProcess | cellular component maintenance | 3.08e-03 | 101 | 17 | 2 | GO:0043954 | |
| GeneOntologyBiologicalProcess | kidney development | 3.28e-03 | 372 | 17 | 3 | GO:0001822 | |
| GeneOntologyBiologicalProcess | exocytic process | 3.45e-03 | 107 | 17 | 2 | GO:0140029 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | 3.60e-03 | 802 | 17 | 4 | GO:0048812 | |
| GeneOntologyBiologicalProcess | renal system development | 3.64e-03 | 386 | 17 | 3 | GO:0072001 | |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | 3.85e-03 | 817 | 17 | 4 | GO:0048514 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | 3.88e-03 | 819 | 17 | 4 | GO:0120039 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | 4.00e-03 | 826 | 17 | 4 | GO:0048858 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 4.31e-03 | 410 | 17 | 3 | GO:0031589 | |
| GeneOntologyBiologicalProcess | tube development | 4.47e-03 | 1402 | 17 | 5 | GO:0035295 | |
| GeneOntologyBiologicalProcess | synaptic vesicle exocytosis | 4.67e-03 | 125 | 17 | 2 | GO:0016079 | |
| GeneOntologyBiologicalProcess | negative regulation of response to wounding | 4.74e-03 | 126 | 17 | 2 | GO:1903035 | |
| GeneOntologyBiologicalProcess | circulatory system development | 5.05e-03 | 1442 | 17 | 5 | GO:0072359 | |
| GeneOntologyBiologicalProcess | neuron development | 5.37e-03 | 1463 | 17 | 5 | GO:0048666 | |
| GeneOntologyBiologicalProcess | biological process involved in interaction with symbiont | 5.42e-03 | 135 | 17 | 2 | GO:0051702 | |
| GeneOntologyBiologicalProcess | developmental growth | 5.67e-03 | 911 | 17 | 4 | GO:0048589 | |
| GeneOntologyBiologicalProcess | vesicle fusion | 5.98e-03 | 142 | 17 | 2 | GO:0006906 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | 6.03e-03 | 927 | 17 | 4 | GO:0030155 | |
| GeneOntologyBiologicalProcess | blood vessel development | 6.08e-03 | 929 | 17 | 4 | GO:0001568 | |
| GeneOntologyBiologicalProcess | organelle membrane fusion | 6.15e-03 | 144 | 17 | 2 | GO:0090174 | |
| GeneOntologyCellularComponent | cytoskeleton of presynaptic active zone | 1.53e-05 | 8 | 16 | 2 | GO:0048788 | |
| GeneOntologyCellularComponent | presynaptic cytoskeleton | 4.97e-05 | 14 | 16 | 2 | GO:0099569 | |
| GeneOntologyCellularComponent | presynaptic active zone cytoplasmic component | 1.38e-04 | 23 | 16 | 2 | GO:0098831 | |
| GeneOntologyCellularComponent | cell cortex region | 5.33e-04 | 45 | 16 | 2 | GO:0099738 | |
| GeneOntologyCellularComponent | platelet alpha granule lumen | 1.18e-03 | 67 | 16 | 2 | GO:0031093 | |
| GeneOntologyCellularComponent | platelet alpha granule | 2.26e-03 | 93 | 16 | 2 | GO:0031091 | |
| GeneOntologyCellularComponent | cortical cytoskeleton | 4.28e-03 | 129 | 16 | 2 | GO:0030863 | |
| GeneOntologyCellularComponent | presynaptic active zone | 5.10e-03 | 141 | 16 | 2 | GO:0048786 | |
| GeneOntologyCellularComponent | blood microparticle | 5.31e-03 | 144 | 16 | 2 | GO:0072562 | |
| GeneOntologyCellularComponent | GABA-ergic synapse | 6.83e-03 | 164 | 16 | 2 | GO:0098982 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 7.10e-03 | 530 | 16 | 3 | GO:0062023 | |
| MousePheno | increased circulating fibrinogen level | 6.44e-06 | 4 | 15 | 2 | MP:0012331 | |
| MousePheno | increased acute phase protein level | 2.25e-05 | 7 | 15 | 2 | MP:0014499 | |
| MousePheno | abnormal circulating fibrinogen level | 3.00e-05 | 8 | 15 | 2 | MP:0010213 | |
| Domain | PDZ | 7.15e-03 | 141 | 17 | 2 | PF00595 | |
| Domain | - | 7.30e-03 | 449 | 17 | 3 | 3.30.40.10 | |
| Domain | Znf_FYVE_PHD | 7.74e-03 | 147 | 17 | 2 | IPR011011 | |
| Domain | Znf_RING/FYVE/PHD | 7.76e-03 | 459 | 17 | 3 | IPR013083 | |
| Domain | PDZ | 7.85e-03 | 148 | 17 | 2 | SM00228 | |
| Domain | - | 8.05e-03 | 150 | 17 | 2 | 2.30.42.10 | |
| Domain | PDZ | 8.16e-03 | 151 | 17 | 2 | PS50106 | |
| Domain | PDZ | 8.26e-03 | 152 | 17 | 2 | IPR001478 | |
| Pathway | REACTOME_DISSOLUTION_OF_FIBRIN_CLOT | 6.09e-05 | 13 | 13 | 2 | M27712 | |
| Pathway | REACTOME_DISSOLUTION_OF_FIBRIN_CLOT | 8.19e-05 | 15 | 13 | 2 | MM15450 | |
| Pathway | WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME | 3.14e-04 | 29 | 13 | 2 | M39890 | |
| Pubmed | Regulation of histidine-rich glycoprotein (HRG) function via plasmin-mediated proteolytic cleavage. | 2.25e-07 | 2 | 17 | 2 | 19712047 | |
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 8478593 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 6438154 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 15220341 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 12163476 | ||
| Pubmed | 1.30e-06 | 1285 | 17 | 7 | 35914814 | ||
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 12391317 | ||
| Pubmed | Fusion Competent Synaptic Vesicles Persist upon Active Zone Disruption and Loss of Vesicle Docking. | 1.35e-06 | 4 | 17 | 2 | 27537483 | |
| Pubmed | ELKS1 Captures Rab6-Marked Vesicular Cargo in Presynaptic Nerve Terminals. | 2.25e-06 | 5 | 17 | 2 | 32521280 | |
| Pubmed | 3.37e-06 | 6 | 17 | 2 | 14734538 | ||
| Pubmed | 3.37e-06 | 6 | 17 | 2 | 19812333 | ||
| Pubmed | 4.23e-06 | 963 | 17 | 6 | 28671696 | ||
| Pubmed | Rebuilding essential active zone functions within a synapse. | 4.72e-06 | 7 | 17 | 2 | 35176221 | |
| Pubmed | Munc13 supports fusogenicity of non-docked vesicles at synapses with disrupted active zones. | 4.72e-06 | 7 | 17 | 2 | 36398873 | |
| Pubmed | Dopamine Secretion Is Mediated by Sparse Active Zone-like Release Sites. | 4.72e-06 | 7 | 17 | 2 | 29398114 | |
| Pubmed | Schwann cell-derived Desert hedgehog controls the development of peripheral nerve sheaths. | 6.29e-06 | 8 | 17 | 2 | 10482238 | |
| Pubmed | 2.04e-05 | 14 | 17 | 2 | 21228161 | ||
| Pubmed | 2.69e-05 | 16 | 17 | 2 | 17601529 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 3.74e-05 | 135 | 17 | 3 | 28675934 | |
| Pubmed | 4.02e-05 | 1431 | 17 | 6 | 37142655 | ||
| Pubmed | 4.82e-05 | 147 | 17 | 3 | 29576527 | ||
| Pubmed | 5.43e-05 | 153 | 17 | 3 | 25037231 | ||
| Pubmed | Redundant functions of RIM1alpha and RIM2alpha in Ca(2+)-triggered neurotransmitter release. | 7.26e-05 | 26 | 17 | 2 | 17124501 | |
| Pubmed | 8.08e-05 | 175 | 17 | 3 | 28071719 | ||
| Pubmed | 1.04e-04 | 31 | 17 | 2 | 15217342 | ||
| Pubmed | α-catenin interaction with YAP/FoxM1/TEAD-induced CEP55 supports liver cancer cell migration. | 1.33e-04 | 35 | 17 | 2 | 37381005 | |
| Pubmed | 1.33e-04 | 35 | 17 | 2 | 33864728 | ||
| Pubmed | The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis. | 1.55e-04 | 218 | 17 | 3 | 33378226 | |
| Pubmed | 2.30e-04 | 46 | 17 | 2 | 25209997 | ||
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 3.26e-04 | 281 | 17 | 3 | 28706196 | |
| Pubmed | 3.91e-04 | 60 | 17 | 2 | 32027825 | ||
| GeneFamily | PDZ domain containing | 2.43e-03 | 152 | 9 | 2 | 1220 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | 4.52e-05 | 893 | 17 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K3 | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast-matrix_-_mature_3|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.82e-05 | 137 | 17 | 3 | 9bfdbc102cdd861996b3c4eac35b606be8af97eb | |
| ToppCell | ICU-NoSEP-Lymphocyte-T_NK-CD4_Naive|ICU-NoSEP / Disease, Lineage and Cell Type | 3.17e-05 | 165 | 17 | 3 | 3d2f6f91a5eee64d01366f35d2cc3cf9ac37ac16 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.47e-05 | 170 | 17 | 3 | 55fe16d98ea284d05fb899888e4569c685644c7b | |
| ToppCell | AT1_cells-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 3.65e-05 | 173 | 17 | 3 | b29816427428c7053017477f59b828bf1357f3b2 | |
| ToppCell | Thalamus-Neuronal-Excitatory|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.84e-05 | 176 | 17 | 3 | d2bbf13d21fb7582d7e5f90cd61a4ebe1cfccd66 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.04e-05 | 179 | 17 | 3 | 4f6ca313b78aa93557937a046c44dcf8bcc9963c | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.11e-05 | 180 | 17 | 3 | 544fb373a3346186ec60afe2cfcf141bb04a1eed | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.11e-05 | 180 | 17 | 3 | 30cf3c7ee29694eaccb89bf8053a82037d5c9f1d | |
| ToppCell | AT1_cells-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 4.11e-05 | 180 | 17 | 3 | ff4728782c3ec814ba071cc22b7894abdd9da837 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.32e-05 | 183 | 17 | 3 | 12daaea821e49bc94a01e2496331e92a80d27339 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.46e-05 | 185 | 17 | 3 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.46e-05 | 185 | 17 | 3 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1|World / Lineage, Cell type, age group and donor | 4.53e-05 | 186 | 17 | 3 | 09d95daa3387a4814cffaa4b798cc2810c3759d0 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.60e-05 | 187 | 17 | 3 | d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.68e-05 | 188 | 17 | 3 | 73f6ec915934154f435a376cb274b058ff7c5f35 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.83e-05 | 190 | 17 | 3 | 474cbbab8f3b0a6881fa6c92edb78e43999f9ab0 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.98e-05 | 192 | 17 | 3 | c618ede75dce3988c87a5b8f98d8e94e1dd66efd | |
| ToppCell | critical-Lymphoid-NK|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.06e-05 | 193 | 17 | 3 | 6be11fef87af04ee7a3cc223882ccd4077caded9 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.06e-05 | 193 | 17 | 3 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | Thalamus-Neuronal|Thalamus / BrainAtlas - Mouse McCarroll V32 | 5.06e-05 | 193 | 17 | 3 | 712a4acd1167e43543950bc819ff11984e6f718d | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.06e-05 | 193 | 17 | 3 | e2b455387d1de7812305200a2041a0f4759a6f54 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.21e-05 | 195 | 17 | 3 | c5d2d9f12fd893331c9de261af30607d845d4f6a | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-MYL4+_SMC|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.37e-05 | 197 | 17 | 3 | 4797f414330316e2ac2cf7cd2570d991877d7a38 | |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-T/NK-CD4+_T_naive|ICU-NoSEP / Disease, condition lineage and cell class | 5.54e-05 | 199 | 17 | 3 | 4cb6faa6ea5d6d36b9969822f572f7a7b3855dad | |
| ToppCell | ASK452-Epithelial-Type_1|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.54e-05 | 199 | 17 | 3 | 48cafe44951908d03f3c6f3e185e9cbb86fb5b3b | |
| ToppCell | Control_saline|World / Treatment groups by lineage, cell group, cell type | 5.54e-05 | 199 | 17 | 3 | 11c9c1779caceb725ecccf3f23b7d4e6dbd1af64 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.54e-05 | 199 | 17 | 3 | a900ef002e1ae583b70be0253d8c44dae6754916 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.62e-05 | 200 | 17 | 3 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 5.62e-05 | 200 | 17 | 3 | 432384faeade8e609154fab3d96c955a8ec868dd | |
| ToppCell | TCGA-Testes-Primary_Tumor-Testicular_Germ_Cell_Tumor-Testicular_Germ_Cell_Tumor-2|TCGA-Testes / Sample_Type by Project: Shred V9 | 8.01e-04 | 111 | 17 | 2 | dbd6a30298c9f3b09b2b5ad93a14305e3438793d | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_9|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.66e-04 | 122 | 17 | 2 | 7dabf8b4c34a3714f45c3a99c1aa159e2d0b7e9c | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_9|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.66e-04 | 122 | 17 | 2 | 489a01c71882be5a6d71a19d06574698988c20f6 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_dendritic-plasmacytoid_dendritic_cell|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.21e-03 | 137 | 17 | 2 | 3f4746fb6fc36c90a8cd25725531a1503422cfbf | |
| ToppCell | 10x5'-Lung-Myeloid_Mac-Intestinal_macrophages|Lung / Manually curated celltypes from each tissue | 1.29e-03 | 141 | 17 | 2 | 7671d300b1722711fd2d8034b96a3aa7e3ccb560 | |
| ToppCell | droplet-Liver-Hepatocytes-24m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-03 | 145 | 17 | 2 | f142b86d4da5b71c189da46cbc4beebdc387ffee | |
| ToppCell | TCGA-Breast-Metastatic-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.43e-03 | 149 | 17 | 2 | 2e9b898f3df22f8e872f2c278eff454c39e55b3b | |
| ToppCell | TCGA-Breast-Metastatic|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.43e-03 | 149 | 17 | 2 | 144ac2c458209ce510674bc2f83eb4c8e4d3c953 | |
| ToppCell | TCGA-Breast-Metastatic-Breast_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.43e-03 | 149 | 17 | 2 | c7dc495141cd921b6b6f291a68851b7b807d0d0a | |
| ToppCell | droplet-Liver-hepatocytes-3m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-03 | 150 | 17 | 2 | ee2da4f684add821f2653d5db8eef46cd95c0fda | |
| ToppCell | droplet-Liver-nan-3m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-03 | 151 | 17 | 2 | b4a0546c1573b4b2290890307f2a5daf3a7cbb37 | |
| ToppCell | droplet-Liver-nan-3m-Epithelial-Hepatocyte_(Pericentral,_Midlobular,_Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-03 | 151 | 17 | 2 | cc9632b58522e2ba3ad36a0b8d37c7c9c8b636c4 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-03 | 151 | 17 | 2 | e243b6c76e59035f10519a86399b598dd2123f87 | |
| ToppCell | droplet-Liver-nan-3m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-03 | 151 | 17 | 2 | 7758cfbe8dca849c90bd6e8bc63310e53beeb8fd | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-03 | 151 | 17 | 2 | cdd2ce0969da446616627e3569bbe5a5d9b475bd | |
| ToppCell | droplet-Liver-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-03 | 152 | 17 | 2 | 1febeeb7376e34b9f86c81b2cb1314ee12408864 | |
| ToppCell | droplet-Liver-nan-3m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-03 | 152 | 17 | 2 | faa92f7c5a6db9f1eb7d8ec930ba7c8ed9fd1bf1 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-03 | 152 | 17 | 2 | c21e2152b0130485659051d8fb7fb4589d1ec997 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Epithelial-Hepatocyte_(Pericentral_and_Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-03 | 154 | 17 | 2 | a5289000597068ee8d559f89bce7bce31f35dd57 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B-Pro-B|bone_marrow / Manually curated celltypes from each tissue | 1.53e-03 | 154 | 17 | 2 | 8a8c3851888ab86ca2b13ccc042cde1fef8d88f8 | |
| ToppCell | normal-na-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.55e-03 | 155 | 17 | 2 | 08295584395e8d9cfc1b1648f98754b3ac53e587 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD8-Tnaive/CM_CD8|Lung / Manually curated celltypes from each tissue | 1.57e-03 | 156 | 17 | 2 | d691a4defda046c1bbcb13ef38ee9abbb628c33c | |
| ToppCell | droplet-Liver-nan-3m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-03 | 157 | 17 | 2 | b72c6a1ed17bfc32d9dec193d934ea82e80b6bd5 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.59e-03 | 157 | 17 | 2 | c43f2e1ea53b375a7432f17f87cfef3b2261003d | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Fibroblasts|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.59e-03 | 157 | 17 | 2 | f086753b51860e23f1275bd75e8802d2a7d7b70a | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-03 | 158 | 17 | 2 | a2efcc184ef13d81373e3690253ba35f6be09c5f | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.61e-03 | 158 | 17 | 2 | 74aa4f75307575ac3b2b1aa9f727753692f88742 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-03 | 158 | 17 | 2 | 9f58428f70d1427b20122c5c1cc7bf521d0f4832 | |
| ToppCell | Healthy/Control-CD8+_T_naive|World / Disease group and Cell class | 1.61e-03 | 158 | 17 | 2 | 70680b29428b6bf882b1fae36f924b775961176b | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-03 | 158 | 17 | 2 | ba9998cbf786c515d30fe42de02c7a246db1b6f9 | |
| ToppCell | facs-Liver|facs / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-03 | 158 | 17 | 2 | ea7db6bd9742153ceb6e444892a6d1df9c7fcc96 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-03 | 158 | 17 | 2 | e52eff2bd1e7e0ce9c278ed5109802865e0fe69c | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Spp1_Col15a1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.63e-03 | 159 | 17 | 2 | 34c90711c5857cf6ada7b3acff99f1d48c7caf29 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.63e-03 | 159 | 17 | 2 | f7bccfeffa737f151417bf52ea45111b0957bce9 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.63e-03 | 159 | 17 | 2 | 7747cef94c55144fddcd024a7495318357f1351b | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Epithelial-Hepatocyte_(Pericentral,_Midlobular,_Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-03 | 160 | 17 | 2 | 8de1fc75241d9bf2b355afa0e9ef39fea1977177 | |
| ToppCell | Healthy_donor-CD8+_T_naive|World / disease group, cell group and cell class (v2) | 1.67e-03 | 161 | 17 | 2 | 8a61395af33132783a0a37956c6f821aba5d3b1e | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.67e-03 | 161 | 17 | 2 | 58381131e651744b5141b202f9d6063f55432db5 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-Tnaive/CM_CD4|Lung / Manually curated celltypes from each tissue | 1.69e-03 | 162 | 17 | 2 | 91cc14aec8d580cf97a1929bc1acb00fcbcdb57a | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-HSC/MPP_and_pro-HSC/MPP|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.69e-03 | 162 | 17 | 2 | e73c644ce1db34f1d390878954e86fa0b3a455a1 | |
| ToppCell | COVID-mono3-|COVID / Condition, Cell_class and T cell subcluster | 1.71e-03 | 163 | 17 | 2 | 26661c7a3a0a449ed32d4b3b28fc2fc0b237025d | |
| ToppCell | droplet-Liver-Hepatocytes-18m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-03 | 163 | 17 | 2 | 7e82c1b7849eca895732df2da74ac6430bd9ba7a | |
| ToppCell | COVID-mono3|COVID / Condition, Cell_class and T cell subcluster | 1.71e-03 | 163 | 17 | 2 | 6ab4cbcd411b40920b81162c0f4b03ea67408f52 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-03 | 163 | 17 | 2 | 1c4de36cf8cdaabb981cda5c7ce7e5ae7b4280e3 | |
| ToppCell | droplet-Liver-Hepatocytes|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-03 | 163 | 17 | 2 | a794540f2d8984f963c08f05175e4bc916fcc224 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-03 | 163 | 17 | 2 | 03d9fa615d9d02ef98e20f28a10aaa6894dd4960 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l15|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.75e-03 | 165 | 17 | 2 | 94a5211072464fc24592bb107a853ce832e816fe | |
| ToppCell | 390C-Lymphocytic-Plasma_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.77e-03 | 166 | 17 | 2 | 4ba3711a02d3695b27f7cefd7c60e3be009f5bef | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-ILC3|GI_small-bowel / Manually curated celltypes from each tissue | 1.77e-03 | 166 | 17 | 2 | 773673a5d0430640439845b264740bfbbdad0cb2 | |
| ToppCell | 390C-Lymphocytic-Plasma_cell-|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.77e-03 | 166 | 17 | 2 | 35f6ae2664935dda0d883b32a050ced843204f2d | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-Tnaive/CM_CD4|Liver / Manually curated celltypes from each tissue | 1.80e-03 | 167 | 17 | 2 | ab6273ae5d76a3f9a05c58320e3dee80f9b99e47 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-NK_cell-NK|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.80e-03 | 167 | 17 | 2 | 42b299273a6c72a625b204d55f4f3c4eebd6d185 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.80e-03 | 167 | 17 | 2 | c87ebfa8c3284ad33579190e148c95bcaf670d17 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-NK_cell|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.80e-03 | 167 | 17 | 2 | 94642b3dae035fedb6e8b9745f440096a4539f3c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-03 | 167 | 17 | 2 | 4e58f9bf1e9d47720c871776ec34513ded4de9b7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-03 | 167 | 17 | 2 | 4ae9f2c5df13463709ea880ab035965fd99e7626 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-NK_cell-NK-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.80e-03 | 167 | 17 | 2 | ecf5bc634e1e01efd783617eb81d1704e903ea21 | |
| ToppCell | control-Myeloid-pDC|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.82e-03 | 168 | 17 | 2 | affc39c7568b7df4b36af6f5b0e3702a18b6268c | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Mac-Intermediate_macrophages|bone_marrow / Manually curated celltypes from each tissue | 1.82e-03 | 168 | 17 | 2 | 8ade4d098aeecda2d80c1cad1cebe9a063eae948 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-03 | 168 | 17 | 2 | 110c3c7c322e04a684a19c2b5434a502279fd000 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-03 | 168 | 17 | 2 | 073b53d4cee6bc8c5c6fce51cf6cd9c316478f69 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-03 | 168 | 17 | 2 | b98af4043dfa5dfa4413e482879fad88de484675 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Lymphocytic-NK/T|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-03 | 168 | 17 | 2 | 735d30cfda1889740bdeb43e39330a52e8f4d599 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-03 | 169 | 17 | 2 | 7785cab967a33560830c394c918d6ce625103858 | |
| ToppCell | AT1-AT2_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 1.84e-03 | 169 | 17 | 2 | 815474855a70498a74e52f6583113c63b7267a0c | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.84e-03 | 169 | 17 | 2 | b66ffc2b2b6bfcc3a6e639d9d31d3de95f4a94e1 | |
| ToppCell | Healthy_donor-CD8+_T_naive|Healthy_donor / disease group, cell group and cell class (v2) | 1.84e-03 | 169 | 17 | 2 | 66216758e581365f10c2a66714d83a606ad23af0 | |
| ToppCell | droplet-Liver-HEPATOCYTES|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-03 | 169 | 17 | 2 | f195467438c589f87224bde7da720dea072d110c | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.84e-03 | 169 | 17 | 2 | 2833a8a7094e4d407eb923f2bc59b9b112c6bae4 | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-03 | 170 | 17 | 2 | d70aaa0f4e5034bb9f61b832b5f9123870936d3c | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 1.86e-03 | 170 | 17 | 2 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| Drug | Resveratrol [501-36-0]; Up 200; 17.6uM; MCF7; HT_HG-U133A | 1.14e-05 | 195 | 17 | 4 | 2865_UP | |
| Drug | dermatan sulfate | 1.83e-05 | 220 | 17 | 4 | CID000032756 | |
| Drug | dysprosium | 2.17e-05 | 74 | 17 | 3 | CID000023912 | |
| Drug | I ms | 3.77e-05 | 89 | 17 | 3 | CID000013551 | |
| Disease | neuroimaging measurement | 2.66e-04 | 1069 | 17 | 5 | EFO_0004346 | |
| Disease | velopharyngeal dysfunction | 2.21e-03 | 122 | 17 | 2 | EFO_0009336 | |
| Disease | parental longevity | 2.66e-03 | 494 | 17 | 3 | EFO_0007796 | |
| Disease | brain measurement, neuroimaging measurement | 3.60e-03 | 550 | 17 | 3 | EFO_0004346, EFO_0004464 | |
| Disease | Alzheimer disease, polygenic risk score | 4.31e-03 | 586 | 17 | 3 | EFO_0030082, MONDO_0004975 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PANHNFPSVARAAPA | 176 | Q9P281 | |
| SRSPQHFHRPGNEPS | 471 | O14639 | |
| RNCPRHHFPRHPNVF | 201 | P04196 | |
| PLSGNSANHHADNPR | 226 | Q6KC79 | |
| PFSARDNPHSHRIQN | 96 | P55268 | |
| GRSQHSNHRPSPDQD | 936 | O15083 | |
| RNAENQPHQPSPRLH | 71 | Q86UR5 | |
| RSFNPGHEHPDQNSF | 461 | Q8IZU8 | |
| HLDHQAAHQPFPRPR | 71 | B1AKI9 | |
| HQPPPIRNLHQSNFS | 526 | Q14194 | |
| NRPHAFNFGPHDNSS | 141 | Q9Y3Y4 | |
| DSNSRNHFQHPLPPQ | 2256 | Q5T011 | |
| SNRQPPSVRPSQHHF | 91 | Q9H0F5 | |
| AQTPHTHNRTPENFP | 301 | P00747 | |
| EPSDHSRHSPQQPSN | 321 | Q07157 | |
| RAHNDHPNNFSRSPP | 1681 | A7E2V4 | |
| HPHSRLNPQPFLQNF | 666 | Q9C0D7 |